Preimplantation Genetic Testing Market by Type (Genetic Diagnosis/Genetic Screening), Technology (NGS, PCR, FISH, CGH, SNP), Products & Services, Application (Aneuploidy, Translocations), End User (Fertility Clinics, Research) - Forecast to 2022
Preimplantation Genetic Testing Market by type 2017-2022 by new Service spreads across 204 pages profiling 17 companies and supported with 85 tables and 42 figures available at ReportsnReports.com do check inquiry here www.reportsnreports.com/contacts/i…aspx?name=1128201
“Preimplantation Genetic Testing Market projected to grow at a CAGR of 10.0%”
The global preimplantation genetic testing market is expected to reach USD 541.8 million by 2022 from USD 336.4million in 2017, at a CAGR of 10.0%. Growing rate of infertility across the globe, increasing public-private investments in the field of preimplantation genetic testing, rising number of fertility clinics worldwide, technological advancements in the field of genetic analysis, and high risk of chromosomal abnormalities in the fetus with increasing maternal age are some of the key factors driving the growth of this market.
However, the high procedural cost associated with preimplantation genetic testing and unsupportive government regulations are the factors restraining the growth of this market
“Next-generation Sequencing is expected to grow at the highest CAGR during 2017 to 2022”
By technology, the preimplantation genetic testing market covers next-generation sequencing (NGS), polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and single-nucleotide polymorphism (SNP). The NGS segment is expected to grow at the highest CAGR during 2017 to 2022, owing to benefits like reduced cost, better ability to detect an embryo with differing results (mosaicism), enhanced detection of structural abnormalities such as chromosomes with missing or duplicate segments, and reduction in human errors due to increased automation.
“The maternity centers & fertility clinics to dominate the global preimplantation genetic testing market during the forecast period”
On the basis of end users, the preimplantation genetic testing market is segmented into maternity centers & fertility clinics; hospitals, diagnostic labs, and service providers; and research laboratories & academic institutes. The maternity centers & fertility clinics segment accounted for the largest share of the global preimplantation genetic testing market in 2016 owing to the high success rate of treatments at fertility centers.
Preimplantation Genetic Diagnosis and Screening Market, By Procedure Type
- Preimplantation Genetic Screening
- Preimplantation Genetic Diagnosis
Preimplantation Genetic Diagnosis and Screening Market, By Technology
- Next-Generation Sequencing
- Polymerase Chain Reaction
- Fluorescence in Situ Hybridization
- Comparative Genomic Hybridization
- Single-Nucleotide Polymorphis
14 Company Profiles
(Overview, Products and Services, Financials, Strategy & Development)*
14.1 Top Product Manufacturers
14.1.1 Illumina, Inc.
14.1.2 Thermo Fisher Scientific Inc.
14.1.3 Agilent Technologies, Inc.
14.1.4 Perkinelmer, Inc.
14.1.5 Coopersurgical, Inc. (A Subsidiary of the Cooper Companies, Inc.)
14.1.6 ABBott Laboratories
14.1.7 Natera, Inc.
14.1.8 Rubicon Genomics (A Subsidiary of Takara Bio Usa Holdings, Inc.)
14.1.9 Oxford Gene Technology
14.1.10 Yikon Genomics
14.2 Top Service Provider Companies
14.2.1 Beijing Genomics Institute
14.2.2 Good Start Genetics, Inc.
14.2.3 Invicta Genetics
14.2.4 Combimatrix Corporation
14.2.5 Genea Limited
*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.